Repurposing an endogenous degradation domain for antibody-mediated disposal of cell-surface proteins
Open Access
- 29 January 2024
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 25 (3) , 951-970
Abstract
The exquisite specificity of antibodies can be harnessed to effect targeted degradation of membrane proteins. Here, we demonstrate targeted protein removal utilising a protein degradation domain derived from the endogenous human protein Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9). Recombinant antibodies genetically fused to this domain drive the degradation of membrane proteins that undergo constitutive internalisation and recycling, including the transferrin receptor and the human cytomegalovirus latency-associated protein US28. We term this approach PACTAC (PCSK9-Antibody Clearance-Targeting Chimeras).Keywords
Funding Information
- Wellcome Trust (WT 207455/Z/17/Z)
- Wellcome Trust (098406/Z/12/B)
- Medical Research Council (MR/S00081X/1)
- Deutsches Zentrum für Infektionsforschung (DZIF MD TI 07.003)
- CIMR Flow Cytometry Core Facility
- Cambridge NIHR BRC Cell Phenotyping Hub
This publication has 64 references indexed in Scilit:
- Myeloblastic Cell Lines Mimic Some but Not All Aspects of Human Cytomegalovirus Experimental Latency Defined in Primary CD34+Cell PopulationsJournal of Virology, 2013
- Characterization of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Trafficking Reveals a Novel Lysosomal Targeting Mechanism via Amyloid Precursor-like Protein 2 (APLP2)Journal of Biological Chemistry, 2013
- A Myeloid Progenitor Cell Line Capable of Supporting Human Cytomegalovirus Latency and Reactivation, Resulting in Infectious ProgenyJournal of Virology, 2012
- Distinct and Overlapping Roles for AP-1 and GGAs Revealed by the “Knocksideways” SystemCurrent Biology, 2012
- SNX17 protects integrins from degradation by sorting between lysosomal and recycling pathwaysJournal of Cell Biology, 2012
- Therapeutic antibodies: successes, limitations and hopes for the futureBritish Journal of Pharmacology, 2009
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences, 2008
- A Versatile Nanotrap for Biochemical and Functional Studies with Fluorescent Fusion ProteinsMolecular & Cellular Proteomics, 2008
- Endocytic recyclingNature Reviews Molecular Cell Biology, 2004
- Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.Journal of Cell Biology, 1983